Answers are grounded in this paper and cite their sources.
OBJECTIVE: Arterially directed therapies for hepatocellular carcinoma are used for patients who are not candidates for surgery or ablation and for those who need a bridge or down-staging to liver transplantation. These therapies seem to prolong the overall survival when compared with supportive care. CONCLUSION: Chemoembolization, particle embolization, drug-eluting beads, and radioembolization have been used for locoregional control. This review discusses patient selection, techniques, safety, clinical outcomes, and imaging findings related to these therapies.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: